Harrisson Sarah A, Ogollah Reuben, Dunn Kate M, Foster Nadine E, Konstantinou Kika
Primary Care Centre Versus Arthritis, School of Medicine, Keele University, UK; North Staffordshire and Stoke-on-Trent Integrated Musculoskeletal Service (NIMS), Midlands Partnership University NHS Foundation Trust, Staffordshire, UK.
Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, UK.
J Pain. 2024 Feb;25(2):533-544. doi: 10.1016/j.jpain.2023.09.016. Epub 2023 Sep 29.
This prospective cohort study investigates the prognosis of patients with neuropathic low back-related leg pain consulting in UK primary care. Data from 511 patients were collected using standardised baseline clinical examinations (including magnetic resonance imaging scan findings), self-report questionnaires at baseline, 4 months, 12 months, and 3 years. Cases of possible neuropathic pain (NP) and persistent-NP were identified using either of 2 definitions: 1) clinical diagnosis of sciatica, 2) self-report version of leeds assessment for neurological symptoms and signs (s-LANSS). Mixed-effects models compared pain intensity (highest of mean leg or mean back pain [0-10 Numerical Rating Scale]) over 3-years between persistent-NP versus non-persistent-NP based on 1) clinical diagnosis, 2) s-LANSS. Logistic regression examined associations between potential prognostic factors and persistent-NP at 4 months based on the 2 NP definitions. At 4-months, using both definitions: 1) approximately 4 out of 10 patients had persistent-NP, 2) mean pain intensity was higher for patients with persistent-NP at all follow-up points compared to those without, 3) only pain self-efficacy was significantly associated with persistent-NP (s-LANSS: OR .98, sciatica: .98), but it did not predict cases of persistent-NP in either multivariable model. Based on factors routinely collected from self-report and clinical examination, it was not possible to predict persistent-NP in this population. PERSPECTIVE: This study provides evidence that neuropathic back-related leg pain in patients consulting in primary care is not always persistent. Patients with persistent neuropathic pain had worse outcomes than those without. Neither leg pain intensity, pain self-efficacy nor MRI scan findings predicted cases of persistent neuropathic pain in this patient population.
这项前瞻性队列研究调查了在英国初级医疗保健机构就诊的患有神经性下背部相关腿痛患者的预后情况。通过标准化的基线临床检查(包括磁共振成像扫描结果)、基线、4个月、12个月和3年时的自我报告问卷,收集了511名患者的数据。使用以下两种定义之一来确定可能的神经性疼痛(NP)和持续性NP病例:1)坐骨神经痛的临床诊断;2)利兹神经症状和体征评估的自我报告版本(s-LANSS)。混合效应模型比较了基于1)临床诊断、2)s-LANSS的持续性NP与非持续性NP患者在3年期间的疼痛强度(腿部平均疼痛或背部平均疼痛的最高值[0-10数字评分量表])。逻辑回归基于两种NP定义,研究了潜在预后因素与4个月时持续性NP之间的关联。在4个月时,使用两种定义:1)约十分之四的患者患有持续性NP;2)与无持续性NP的患者相比,持续性NP患者在所有随访点的平均疼痛强度更高;3)只有疼痛自我效能与持续性NP显著相关(s-LANSS:OR.98,坐骨神经痛:.98),但在任何多变量模型中它都不能预测持续性NP病例。基于从自我报告和临床检查中常规收集的因素,无法预测该人群中的持续性NP。观点:本研究提供了证据表明,在初级医疗保健机构就诊的患者中,神经性背部相关腿痛并不总是持续性的。患有持续性神经性疼痛的患者比无此症状的患者预后更差。在该患者群体中,腿部疼痛强度、疼痛自我效能或磁共振成像扫描结果均不能预测持续性神经性疼痛病例。